In this study, we demonstrated that bosentan may be an effective treatment in patients with atherosclerosis, particularly as this drug led to major reductions in the atherosclerosis plaques of ApoE-deficient mice in vivo. The gene discussed is APOE; the disease is atherosclerosis.